Revolution Medicines, Inc. (RVMDW) Operating margin 2018–2023
Revolution Medicines, Inc. (RVMDW) operating margin by fiscal year — reported operating income divided by reported revenue.
-4207.1%FY2023 · since FY2018: -200.0% → -4207.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -4207.1% | -3477.1 pp |
| FY2022 | -730.0% | -90.3 pp |
| FY2021 | -639.7% | -382.2 pp |
| FY2020 | -257.5% | -149.4 pp |
| FY2019 | -108.2% | +91.8 pp |
| FY2018 | -200.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating incomeRVMDW Operating cash flowRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →